1. Home
  2. PFSI vs CRL Comparison

PFSI vs CRL Comparison

Compare PFSI & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFSI
  • CRL
  • Stock Information
  • Founded
  • PFSI 2008
  • CRL 1947
  • Country
  • PFSI United States
  • CRL United States
  • Employees
  • PFSI N/A
  • CRL N/A
  • Industry
  • PFSI Finance: Consumer Services
  • CRL Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • PFSI Finance
  • CRL Health Care
  • Exchange
  • PFSI Nasdaq
  • CRL Nasdaq
  • Market Cap
  • PFSI 6.9B
  • CRL 7.3B
  • IPO Year
  • PFSI 2013
  • CRL 2000
  • Fundamental
  • Price
  • PFSI $129.47
  • CRL $185.45
  • Analyst Decision
  • PFSI Buy
  • CRL Buy
  • Analyst Count
  • PFSI 6
  • CRL 16
  • Target Price
  • PFSI $138.67
  • CRL $190.86
  • AVG Volume (30 Days)
  • PFSI 422.6K
  • CRL 1.0M
  • Earning Date
  • PFSI 10-21-2025
  • CRL 11-05-2025
  • Dividend Yield
  • PFSI 0.92%
  • CRL N/A
  • EPS Growth
  • PFSI 189.98
  • CRL N/A
  • EPS
  • PFSI 9.29
  • CRL N/A
  • Revenue
  • PFSI $2,965,619,000.00
  • CRL $4,028,615,000.00
  • Revenue This Year
  • PFSI $6.07
  • CRL N/A
  • Revenue Next Year
  • PFSI $24.34
  • CRL $2.43
  • P/E Ratio
  • PFSI $14.01
  • CRL N/A
  • Revenue Growth
  • PFSI 47.97
  • CRL N/A
  • 52 Week Low
  • PFSI $85.74
  • CRL $91.86
  • 52 Week High
  • PFSI $134.56
  • CRL $230.02
  • Technical
  • Relative Strength Index (RSI)
  • PFSI 62.35
  • CRL 59.20
  • Support Level
  • PFSI $128.68
  • CRL $184.88
  • Resistance Level
  • PFSI $134.08
  • CRL $199.66
  • Average True Range (ATR)
  • PFSI 3.83
  • CRL 5.73
  • MACD
  • PFSI 1.00
  • CRL 0.77
  • Stochastic Oscillator
  • PFSI 74.48
  • CRL 56.68

About PFSI PennyMac Financial Services Inc.

PennyMac Financial Services Inc is a specialty financial services firm with a comprehensive mortgage platform and integrated business focused on the production and servicing of U.S. residential mortgage loans. The company operates through two segments: production and servicing. The production segment performs loan origination, acquisition and sale activities. The servicing segment performs loan servicing for newly originated loans.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: